TOKYO, March 18 (Xinhua) — Tokyo stocks rose on Wednesday after the benchmark Nikkei stock index declined for four consecutive trading days, driven up by dip-buying as energy price pressures eased from recent highs.
The 225-issue Nikkei…
Category: 6. Business
-
Isracard to buy digital bank Esh
The move will pave the way for Isracard, controlled by Yitzhak Tshuva’s Delek Group, to become a major banking player.
Continue Reading
-
S. Korea raises oil crisis alert, prepares to release reserves-Xinhua
SEOUL, March 18 (Xinhua) — South Korea on Wednesday raised its oil crisis alert from “attention” to “caution” level and is preparing to release strategic petroleum reserves amid growing concerns over supply disruptions, Yonhap News Agency…
Continue Reading
-
S. Korea raises oil crisis alert, prepares to release reserves-Xinhua
SEOUL, March 18 (Xinhua) — South Korea on Wednesday raised its oil crisis alert from “attention” to “caution” level and is preparing to release strategic petroleum reserves amid growing concerns over supply disruptions, Yonhap News Agency…
Continue Reading
-
Singapore Intermodal Fuel Fee Update 2026
Due to the ongoing volatility in the Middle East and its impact on global oil production and refining, the logistics sector continues to face rapid and significant increases in fuel prices. To ensure uninterrupted service across our…
Continue Reading
-
Asia Equities Gain Ahead of Fed, Oil Retreats But Stays High – WSJ
- Asia Equities Gain Ahead of Fed, Oil Retreats But Stays High WSJ
- Asian stocks rally as oil retreats, Fed in spotlight Reuters
- Asian Stocks Gain Before Fed, Oil Holds Near $103: Markets Wrap Bloomberg.com
- Asia stocks: Nikkei, KOSPI lead gains on…
Continue Reading
-
Stock market today: Live updates
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., March 17, 2026.
Brendan McDermid | Reuters
Stock futures traded higher early Wednesday as traders awaited the Federal Reserve’s rate policy decision.
Futures…
Continue Reading
-
Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer
- Primary endpoint met in first randomized Phase 2 study, FOURLIGHT-1, showing a 40% reduction in the risk of disease progression or death with manageable safety profile
- More than 90% of patients initiated atirmociclib within 3 months of prior…
Continue Reading
-
'Fuels costs are putting our customers off driving' – BBC
- ‘Fuels costs are putting our customers off driving’ BBC
- ‘Fuel costs are putting our customers off travel’ BBC
- ‘Daylight robbery’: M1 drivers boggle at the rising price of fuel | Petrol prices The Guardian
- Diesel on ‘crash course’ to 170p…
Continue Reading
-
Stocks Rally in Runup to Fed Meeting, Oil Drops: Markets Wrap
(Bloomberg) — Equities rallied for a third day as renewed optimism around artificial intelligence underpinned risk appetite…
Continue Reading